MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/pr9.0000000000001426

Медицинская библиотека · Pain reports · 2026

Analgesic strategies for ischaemic pain in chronic limb-threatening ischaemia: a systematic review and meta-analysis.

Davies Henry, Boalot Ahmed, Howitt Annabel, Vleugels Marie-José, Tam Sharon Ka Po, Kwan Jing Yi, Black Sheila, Francis Ingrid, Bull Christopher, Mees Barend M E, Mitchell Sarah, Russell David

СтатьяОбзорПеревод пока не подготовлен

Аннотация

To evaluate the effectiveness of pharmacological (eg, ketamine, lidocaine) and nonpharmacological (eg, spinal cord stimulation, mononuclear cell therapy) analgesic strategies-outside the WHO pain ladder-for patients with chronic limb-threatening ischaemia (CLTI). A systematic review and meta-analysis was conducted in accordance with PRISMA guidelines, searching 5 electronic databases for studies evaluating analgesia in CLTI. Both randomised and nonrandomised studies were included. Standardised mean differences (SMDs) in post-treatment pain scores were extracted or calculated, and random-effects meta-analyses performed for comparable studies. Twenty-one studies met inclusion criteria. Most investigated mononuclear cell therapy, hepatocyte growth factor, or prostaglandin infusions. Meta-analyses of mononuclear cell therapy vs standard treatment at 3 months showed significant benefit (3 studies; SMD = -2.12, 95% confidence interval [CI] -3.19 to -1.05, P = 0.001, I2 = 86.95%). At 6 months, benefit persisted (3 studies; SMD = -2.54, 95% CI -3.95 to -1.14, P = 0.0004, I2 = 92.0%). Across studies, mononuclear cell therapy showed the largest effect sizes but was associated with high heterogeneity and, due to restrictive exclusion criteria, had limited generalisability and poor practicality. Hepatocyte growth factor therapy showed a nonsignificant trend towards pain reduction, and prostaglandin infusion demonstrated no meaningful effect; both excluded large proportions of the CLTI cohort. Of the single-study interventions, subcutaneous lidocaine and ketamine provided short-term analgesic benefit with acceptable safety, whereas others did not produce statistically significant improvements. Pharmacological management of pain in CLTI remains challenging. No recommendations can be made for agents outside standard care. Several novel approaches, including ketamine and subcutaneous lidocaine, warrant further investigation. Further research into novel analgesics for CLTI is urgently needed.

Для цитирования: Davies Henry, Boalot Ahmed, Howitt Annabel, Vleugels Marie-José, Tam Sharon Ka Po, Kwan Jing Yi, Black Sheila, Francis Ingrid, Bull Christopher, Mees Barend M E, Mitchell Sarah, Russell David. Analgesic strategies for ischaemic pain in chronic limb-threatening ischaemia: a systematic review and meta-analysis.. Pain reports. 2026. DOI: 10.1097/pr9.0000000000001426.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.